Target expression is a relevant factor in synthetic lethal screens

Target expression is a relevant factor in synthetic lethal screens

Bibliographic Details
Main Authors:	Iman J. Schultz, Herjan J. T. Coelingh Bennink
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-08-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-022-03746-6

Similar Items

Reply to: Target expression is a relevant factor in synthetic lethal screens
by: Yosi Gilad, et al.
Published: (2022-08-01)

Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review
by: Herjan J.T. Coelingh Bennink, et al.
Published: (2022-12-01)

A tumor cell specific Zona Pellucida glycoprotein 3 RNA transcript encodes an intracellular cancer antigen
by: Iman J. Schultz, et al.
Published: (2023-12-01)

Protocol for Comprehensive Synthetic Lethality Screens
by: Damia Romero-Moya, et al.
Published: (2020-06-01)

Exploiting synthetic lethal interactions for targeted cancer therapy
by: Reinhardt, H. Christian, et al.
Published: (2012)

Cancer Metabolism as a Therapeutic Target: Metabolic Synthetic Lethality.
by: Bensaad, K, et al.
Published: (2013)

Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
by: Tsang Patricia S, et al.
Published: (2012-03-01)

Synthetic lethal approaches to target cancers with loss of PTEN function
by: Ayse Ertay, et al.
Published: (2023-11-01)

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
by: Sara Costa-Cabral, et al.
Published: (2017-01-01)

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
by: Sara Costa-Cabral, et al.
Published: (2016-01-01)

Synthetic lethal vulnerabilities of cancer.
by: Fece de la Cruz, F, et al.
Published: (2015)

Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy
by: Ananna Bhadra Arna, et al.
Published: (2023-01-01)

The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality
by: Chandler Bray, et al.
Published: (2023-09-01)

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
by: Shuangying Li, et al.
Published: (2022-10-01)

Literature-based translation from synthetic lethality screening into therapeutics targets: CD82 is a novel target for KRAS mutation in colon cancer
by: Hsih-Te Yang, et al.
Published: (2022-01-01)

Cancer‐associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7
by: Joseph S. Baxter, et al.
Published: (2024-02-01)

Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
by: Sara Costa-Cabral, et al.
Published: (2018-01-01)

Synthetic lethality: general principles, utility and detection using genetic screens in human cells.
by: Nijman, S
Published: (2011)

Synthetic Lethality Screens Using RNAi in Combination with CRISPR-based Knockout in Drosophila Cells
by: Benjamin Housden, et al.
Published: (2017-02-01)

Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
by: Sumana Srivatsa, et al.
Published: (2022-12-01)

Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
by: Lipika R. Pal, et al.
Published: (2022-05-01)

Cancer. Potential of the synthetic lethality principle.
by: Nijman, S, et al.
Published: (2013)

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer
by: Herjan J. T. Coelingh Bennink, et al.
Published: (2023-05-01)

Genetic screening for anticancer genes highlights FBLN5 as a synthetic lethal partner of MYC
by: Motasim Masood, et al.
Published: (2023-10-01)

Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers
by: Stephan Krieg, et al.
Published: (2024-06-01)

Generation of dual-gRNA library for combinatorial CRISPR screening of synthetic lethal gene pairs
by: Shan Tang, et al.
Published: (2022-09-01)

Targeting werner helicase with synthetic lethality in microsatellite instability cancers: Promising therapeutic approaches
by: Huanzhang Xie, et al.
Published: (2024-06-01)

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
by: Zhang Yang, et al.
Published: (2022-01-01)

Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma
by: Viviana Vella, et al.
Published: (2024-04-01)

Mslar: Microbial synthetic lethal and rescue database.
by: Sen-Bin Zhu, et al.
Published: (2023-06-01)

Synthetic lethality and the minimal genome size problem
by: Sara Rahiminejad, et al.
Published: (2024-07-01)

Advances in synthetic lethality modalities for glioblastoma multiforme
by: Richard Seidu A.
Published: (2024-06-01)

Synthetic Lethality Approaches in Acute Lymphoblastic Leukemia
by: Francisco Alejandro Lagunas-Rangel, et al.
Published: (2023-12-01)

Paralog-based synthetic lethality: rationales and applications
by: Yucui Xin, et al.
Published: (2023-06-01)

Nitric Oxide: Genomic Instability And Synthetic Lethality
by: Vasily A. Yakovlev
Published: (2015-08-01)

SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
by: Linda Zhang, et al.
Published: (2024-06-01)

Synthetic lethality of cohesins with PARPs and replication fork mediators.
by: Jessica L McLellan, et al.
Published: (2012-01-01)

Cohesin mutations are synthetic lethal with stimulation of WNT signaling
by: Chue Vin Chin, et al.
Published: (2020-12-01)

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
by: Jonathan So, et al.
Published: (2022-10-01)

Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review
by: Herjan J T Coelingh Bennink, et al.
Published: (2022-11-01)